Page last updated: 2024-09-03

ym 529 and Astrocytoma, Grade IV

ym 529 has been researched along with Astrocytoma, Grade IV in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hironaka, Y; Matsuda, R; Motoyama, Y; Nakagawa, I; Nakamura, M; Nakase, H; Nakazawa, T; Nishimura, F; Omoto, K; Ouji, Y; Park, YS; Takeshima, Y; Tamura, K; Tanaka, Y; Tsujimura, T; Yamada, S; Yokota, H; Yoshikawa, M1

Other Studies

1 other study(ies) available for ym 529 and Astrocytoma, Grade IV

ArticleYear
Antitumor effects of minodronate, a third-generation nitrogen-containing bisphosphonate, in synergy with γδT cells in human glioblastoma in vitro and in vivo.
    Journal of neuro-oncology, 2016, Volume: 129, Issue:2

    Topics: Amino Acid Chloromethyl Ketones; Animals; Annexin A5; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Caspase Inhibitors; Cell Count; Cell Line, Tumor; Cell Proliferation; Diphosphonates; Female; Glioblastoma; Humans; Imidazoles; Intraepithelial Lymphocytes; Male; Mice, Inbred NOD; Signal Transduction; Xenograft Model Antitumor Assays

2016